Association between serum antibodies to oral microorganisms and hyperglycemia in adults

Journal of Dental Research

Volumn 93, Issue 8, 2014, Pages 752-759

  Merchant, A T ^a   Shrestha, D ^a   Chaisson, C ^a   Choi, Y H ^b   Hazlett, L J ^a   Zhang, J ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Kyungpook National University   (South Korea)

Author keywords

antibody titer; diabetes; HbA1c; periodontal diseases; periodontal microorganisms; prediabetic state

Indexed keywords

BACTERIUM ANTIBODY; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN G; INSULIN;

ADULT; ANALYSIS; BLOOD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; EDENTULOUSNESS; FEMALE; GLUCOSE BLOOD LEVEL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYPERGLYCEMIA; IMMUNOLOGY; IMPAIRED GLUCOSE TOLERANCE; MALE; MICROBIOLOGY; MIDDLE AGED; NUTRITION; PERIODONTAL DISEASE;

ADULT; ANTIBODIES, BACTERIAL; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; IMMUNOGLOBULIN G; INSULIN; JAW, EDENTULOUS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PERIODONTAL DISEASES; PREDIABETIC STATE;

EID: 84905843092     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514538451     Document Type: Article

References (32)

1. Borgnakke WS, Ylöstalo PV, Taylor GW, Genco RJ. Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Periodontol. 2013 ; 84 (4). 135S - 152S
2. Casarin RC, Barbagallo A, Meulman T, Santos VR, Sallum EA, Nociti FH, et al. Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. J Periodontal Res. 2013 ; 48: 30-36
3. Centers for Disease Control and Prevention (2008). NHANES III: antibodies to periodontal pathogens. URL accessed on 5/14/2014 at: ftp://ftp.cdc.gov/pub/ health-statistics/NCHS/nhanes/nhanes3/30a/spsdeppx.pdf.
4. Choi YH, McKeown RE, Mayer-Davis EJ, Liese AD, Song KB, Merchant AT. Association between periodontitis and impaired fasting glucose and diabetes. Diabetes Care. 2011 ; 34: 381-386
5. da Cruz GA, de Toledo S, Sallum EA, Sallum AW, Ambrosano GM, de Cássia Orlandi Sardi J, et al. Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus. J Periodontol. 2008 ; 79: 1150-1157
6. Demmer RT, Squillaro A, Papapanou PN, Rosenbaum M, Friedewald WT, Jacobs DR, et al. Periodontal infection, systemic inflammation, and insulin resistance: results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004. Diabetes Care. 2012 ; 35: 2235-2242
7. Desvarieux M, Demmer RT, Jacobs DR, Papapanou PN, Sacco RL, Rundek T. Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness: the oral infections and vascular disease epidemiology study. J Am Heart Assoc. 2013 ; 2: e000254
8. Ebersole JL, Holt SC, Hansard R, Novak MJ. Microbiologic and immunologic characteristics of periodontal disease in Hispanic americans with type 2 diabetes. J Periodontol. 2008 ; 79: 637-646
9. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012 ; 91: 914-920
10. Engebretson S, Kocher T. Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis. J Clin Periodontol. 2013 ; 40: 153-163
11. Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, et al. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial. JAMA. 2013 ; 310: 2523-2532
12. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat. 1992 ; 113: 1-35
13. Field CA, Gidley MD, Preshaw PM, Jakubovics N. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes. J Periodontal Res. 2012 ; 47: 470-478
14. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011 ; 29: 415-445
15. Haffajee AD, Teles RP, Socransky SS. Association of Eubacterium nodatum and Treponema denticola with human periodontitis lesions. Oral Microbiol Immunol. 2006 ; 21: 269-282
16. Hayashi C, Madrigal AG, Liu X, Ukai T, Goswami S, Gudino CV, et al. Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. J Innate Immun. 2010 ; 2: 334-343
17. Kudo C, Naruishi K, Maeda H, Abiko Y, Hino T, Iwata M, et al. Assessment of the plasma/serum IgG test to screen for periodontitis. J Dent Res. 2012 ; 91: 1190-1195
18. Lakio L, Antinheimo J, Paju S, Buhlin K, Pussinen PJ, Alfthan G. Tracking of plasma antibodies against Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis during 15 years. J Oral Microbiol. 2009 ;:
19. Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011 ; 7: 738-748
20. Makiura N, Ojima M, Kou Y, Furuta N, Okahashi N, Shizukuishi S, et al. Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. Oral Microbiol Immunol. 2008 ; 23: 348-351
21. Okada M, Kobayashi T, Ito S, Yokoyama T, Abe A, Murasawa A, et al. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis. J Periodontol. 2013 ; 84: e74 - e84
22. Papapanou PN, Neiderud AM, Papadimitriou A, Sandros J, Dahlén G. "Checkerboard" assessments of periodontal microbiota and serum antibody responses: a case-control study. J Periodontol. 2000 ; 71: 885-897
23. Papapanou PN, Neiderud AM, Sandros J, Dahlén G. Checkerboard assessments of serum antibodies to oral microbiota as surrogate markers of clinical periodontal status. J Clin Periodontol. 2001 ; 28: 103-106
24. Papapanou PN, Neiderud AM, Disick E, Lalla E, Miller GC, Dahlén G. Longitudinal stability of serum immunoglobulin G responses to periodontal bacteria. J Clin Periodontol. 2004 ; 31: 985-990
25. Sgolastra F, Severino M, Pietropaoli D, Gatto R, Monaco A. Effectiveness of periodontal treatment to improve metabolic control in patients with chronic periodontitis and type 2 diabetes: a meta-analysis of randomized clinical trials. J Periodontol. 2013 ; 84: 958-973
26. Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol. 2002 ; 2000: 28 12-55
27. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol. 2005 ; 2000: 38 135-187
28. VanderWeele TJ. Mediation and mechanism. Eur J Epidemiol. 2009 ; 24: 217-224
29. Vlachojannis C, Dye BA, Herrera-Abreu M, Pikdöken L, Lerche-Sehm J, Pretzl B, et al. Determinants of serum IgG responses to periodontal bacteria in a nationally representative sample of US adults. J Clin Periodontol. 2010 ; 37: 685-696
30. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine: reporting of subgroup analyses in clinical trials. N Engl J Med. 2007 ; 357: 2189-2194
31. Yuan K, Chang CJ, Hsu PC, Sun HS, Tseng CC, Wang JR. Detection of putative periodontal pathogens in non-insulin-dependent diabetes mellitus and non-diabetes mellitus by polymerase chain reaction. J Periodontal Res. 2001 ; 36: 18-24
32. Zhou M, Rong R, Munro D, Zhu C, Gao X, Zhang Q, et al. Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing. PLoS One. 2013 ; 8: e61516